TZIANABOS ARTHUR 4
4 · Stoke Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
TZIANABOS ARTHUR
DirectorInterim Executive Chair
Transactions
- Award
Director Stock Option (Right to Buy)
2024-06-05+7,639→ 7,639 totalExercise: $16.41Exp: 2034-06-04→ Common Stock (7,639 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earlier of: (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.